Johnson & Johnson announced it has reached an agreement to resolve the outstanding ovarian talc litigation. The comprehensive resolution is designed to address the remaining claims from plaintiff firms leading the federal Multi-District Litigation (MDL) and related state court proceedings.
Key Details
- Financial Commitment: The agreement includes a total commitment of $5.5 billion from the company.
- Payment Terms: An initial payment of up to $3 billion will be made in 2027, with no additional payments due before 2028.
- Contingency: The resolution is conditioned on the participation of at least 95% of the remaining ovarian talc claims.